Related Experiment Video
Updated: May 20, 2026

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
Published on: March 1, 2011
Heart failure biomarkers: focus on interleukin-1 receptor-like 1-based blood tests
K Broch1, T Ueland, A Yndestad
1Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. kaspar.broch@ous-hf.no
Insights
Elevated levels of soluble Interleukin-1 receptor-like 1 (IL1RL1), also known as ST2, indicate a worse prognosis in heart failure patients. This biomarker reflects inflammation and stress, offering valuable prognostic information.
Area of Science:
- Cardiology
- Immunology
- Biomarker Research
Background:
- Heart failure is a major cause of death with complex pathophysiology.
- Biomarkers are crucial for understanding and managing heart failure.
- Interleukin-1 receptor-like 1 (IL1RL1), or ST2, is linked to inflammation and cardiac stress.
Purpose of the Study:
- To investigate the prognostic value of soluble IL1RL1 isoform B in heart failure.
- To determine if IL1RL1 concentration correlates with adverse outcomes in heart failure patients.
Main Methods:
- Analysis of plasma/serum concentrations of soluble IL1RL1 isoform B.
- Correlation of IL1RL1 levels with heart failure outcomes across various patient cohorts.
Main Results:
- Elevated soluble IL1RL1 isoform B levels are strongly associated with adverse outcomes in heart failure.
- This association is independent of patient age, heart failure cause, and left ventricular function.
Conclusions:
- Soluble IL1RL1 (ST2) is a significant prognostic biomarker in heart failure.
- The IL-33/IL1RL1 pathway presents a potential therapeutic target for heart failure management.
Abstract:
Heart failure is a leading cause of morbidity and mortality in the Western world. It is often a progressive disease, and the pathophysiology behind this adverse development is not completely understood. Biomarkers are of increasing importance in heart failure research. Despite a growing number of candidate markers, only a select few have made it into clinical practice. Interleukin-1 receptor-like 1 (IL1RL1), also known as protein ST2, is the receptor for interleukin-33 (IL-33), a cytokine involved in T-cell-mediated immune responses. IL1RL1 expression is induced by cardiomyocyte stretch, and IL1RL1 may thus reflect the activity of two interacting processes in heart failure: inflammation and hemodynamic stress. In recent years, the soluble, truncated IL1RL1 isoform B has been shown to provide prognostic information in heart failure. Although ILRL1 isoform B does not seem to aid in the diagnosis of the disease, an elevated plasma/serum concentration of this marker is firmly associated with adverse outcome in patients with heart failure. This association has been established in different heart failure cohorts and is independent of age, etiology of heart failure and left ventricular function. Ultimately, the IL-33/IL1RL1 pathway may become a therapeutic target in heart failure.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Heart Failure II: Pathophysiology
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests

